# Buprenorphine

NDC: 69238-1203
Generic name: Buprenorphine
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20200420

FDA application: ANDA211586

## Active ingredients

- BUPRENORPHINE: 10 ug/h

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-1203"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-1203
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7d079fb-507f-436f-b794-2171b7d97067